Coral Gables, Florida 33134


This study will evaluate the safety and effectiveness of JUVÉDERM VOLUX™ XC injectable gel for restoring jawline definition


Inclusion Criteria: - Has "Moderate" or "Severe" loss of jawline definition as determined by the EI using the ALJDs (Grade 2 or 3 on the ALJDS) on both sides. The grade does not have to be the same on both sides, but must be Grade 2 or 3 - Treating Investigator (TI) considers the subject's jaw amenable to an improvement of at least 1 grade on the scale for the jawline definition - Written Informed Consent (IC) has been obtained Exclusion Criteria: - Has ever received permanent facial implants (eg, polymethylmethacrylate, silicone, polytetrafluoroethylene) anywhere in the face or neck, or is planning to be implanted with any of these products during the study - Has ever undergone fat injections in the malar, chin or jawline area or is planning to undergo this procedure during the study - Has undergone semipermanent dermal filler treatment (eg, calcium hydroxyapatite, poly-L-lactic acid) below the subnasale within 36 months before enrollment or is planning to undergo such treatment during the study - Has received deoxycholic acid treatment in the submental region in the last 6 months - Has active autoimmune disease - Females who are pregnant, nursing, or planning a pregnancy during the course of the study



Primary Contact:

Study Director
Candice Harvey

Clinical Trials Registry Team
Phone: 877-277-8566

Backup Contact:


Location Contact:

Coral Gables, Florida 33134
United States

Study Coordinator
Phone: 305-443-9977

Site Status: Recruiting

Data Source:

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.